Nium and Thredd Expand Partnership to Power B2B Travel Payments in APAC
SINGAPORE, April 23, 2024 /PRNewswire/ — Nium, the global leader in real-time cross-border payments, today announced the expansion of its partnership with Thredd, a leading global payments processor, to issue virtual cards in the Asia Pacific (APAC) region. Nium’s virtual card solu
An adventure every day after school: Boys and Girls Clubs of Central Arizona
PRESCOTT and PRESCOTT VALLEY, Ariz., April 23, 2024 /PRNewswire/ — The Boys and Girls Clubs of Central Arizona proudly announce their ongoing commitment to youth development in the Prescott and Prescott Valley communities. As a cornerstone of local enrichment and learning, the Clubs provide a
Ameristar Windows: Pioneering Accountability in American Manufacturing
TEMECULA, Calif., April 23, 2024 /PRNewswire/ — Ameristar Windows, a standout in American manufacturing, has redefined industry standards by integrating all operations—manufacturing, delivery, and installation—within its Southern California facilities. This approach ensures premium qualit
Discover affordable fares with PLAY airlines for your transatlantic journeys
REYKJAVIK, Iceland, April 24, 2024 /PRNewswire/ — PLAY airlines offers affordable travel options between North America and Europe. Since its inaugural flight in 2021, PLAY has expanded its fleet to include 10 aircraft from the Airbus A320 family and with an average aircraft age of just over 2
Veritas Strengthens Cyber Resilience with New AI-Powered Solutions
Launches industry’s first self-defending data protection solutionAnnounces new AI-powered copilotExpands Veritas 360 Defense with new security partners SINGAPORE, April 24, 2024 /PRNewswire/ — Veritas Technologies, the leader in secure multi-cloud data resilience, today announced artif
Hanmi Enters into Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate BH3120 in Combination with KEYTRUDA® (pembrolizumab)
Hanmi Pharmaceutical announces Clinical Trial Collaboration with MSD to evaluate ‘BH3120’ in combination with KEYTRUDA in phase 1 clinical trial in patients with progressive or metastatic solid tumors SEOUL, South Korea, April 23, 2024 /PRNewswire/ — Hanmi Pharmaceutical (KOSPI: 12
Astellas’ XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting
XTANDI is now the first and only novel hormone therapy available for the treatment of high-risk biochemical recurrent non-metastatic hormone-sensitive prostate cancer in the European Union (EU) XTANDI can be given alone or in combination with androgen deprivation therapy Approval is based on results
GLN International successfully debuts at Money 20/20 Asia
SEOUL, South Korea, April 24, 2024 /PRNewswire/ — GLN International CEO, Kyung-ho Kim, joined as a speaker at Money20/20 Asia, the world’s leading fintech event. Money 20/20 Asia takes place in Queen Sirikit National Convention Center (QSNCC), Bangkok, Thailand. By pitching GLN’s s
Clorox to Present at Goldman Sachs Global Staples Forum
OAKLAND, Calif., April 23, 2024 /PRNewswire/ — The Clorox Company (NYSE: CLX) today announced that Chair and Chief Executive Officer Linda Rendle will participate in a fireside chat at the Goldman Sachs Global Staples Forum on Tuesday, May 14, 2024. The webcast will begin at approximately 8
University of Maryland’s Smith School of Business Launches Center for Artificial Intelligence in Business
COLLEGE PARK, Md., April 23, 2024 /PRNewswire/ — The University of Maryland’s Robert H. Smith School of Business has launched the Center for Artificial Intelligence in Business to conduct research and outreach in order to realize the potential of AI through intentional design and governa